Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15
Closed -$1.16K 1751
2026
Q1
$1.16K Buy
15
+2
+15% +$150 ﹤0.01% 927
2025
Q4
$974 Buy
13
+7
+117% +$511 ﹤0.01% 839
2025
Q3
$374 Sell
6
-2
-25% -$133 ﹤0.01% 883
2025
Q2
$570 Sell
8
-51
-86% -$3.06K ﹤0.01% 838
2025
Q1
$3.66K Sell
59
-5
-8% -$331 ﹤0.01% 634
2024
Q4
$4.61K Buy
64
+13
+25% +$1.02K ﹤0.01% 567
2024
Q3
$4.17K Buy
51
+26
+104% +$2.08K ﹤0.01% 598
2024
Q2
$1.84K Buy
25
+5
+25% +$375 ﹤0.01% 578
2024
Q1
$1.54K Buy
20
+3
+18% +$223 ﹤0.01% 556
2023
Q4
$1.19K Buy
+17
New +$1.18K ﹤0.01% 572

Other funds holding HOLX

Dunhill Financial's HOLX Position: Q2 2026 in Review

Dunhill Financial sold out of Hologic (HOLX) in Q2 2026, closing a stake of 15 shares — an estimated $1.16K sold.

Dunhill Financial first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $4.61K in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Dunhill Financial reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Dunhill Financial sold 15 Hologic shares in Q2 2026, an estimated $1.16K.
  • Dunhill Financial first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • Dunhill Financial's Hologic position peaked at $4.61K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.